ELICIO THERAPEUTICS, INC. (ELTX)
Elicio Therapeutics Announces Activation of the Investigator-Initiated Phase 1 Study of Neoadjuvant ELI-002 7P for Pancreatic Ductal Adenocarcinoma
Elicio Therapeutics Announces Activation of the Investigator-Initiated Phase 1 Study of Neoadjuvant ELI-002 7P for Pancreatic Ductal Adenocarcinoma
Alvotech to Report Financial Results for H1 2026
High Roller Technologies to Present at the Sidoti August Virtual Micro-Cap Conference
Boston Scientific announces participation in Wells Fargo 21st Annual Healthcare Conference and conference call discussing third quarter 2026 results
BorgWarner Announces Cash Tender Offers for its Senior Notes
Revvity Launches SuperFlex Prenatal Screening System, Expanding Access to Preeclampsia Testing
Motorcar Parts of America Reports Fiscal 2027 First Quarter Results
Mitesco Announces Capital Structure Improvements for the Benefit of Shareholders
Onto Innovation Completes Strategic Investment in Rigaku Holdings Corporation
Omeros Corporation to Announce Second Quarter Financial Results on August 12, 2026
Quanterix Releases Financial Results for the Second Quarter of 2026
The RBC iShares Alliance Expands Lineup with Two New ETFs
MPT Announces Agreement for $2.4 Billion Private Refinancing Transaction Expected to Extend Debt Maturities to 2032 and Reduce Debt by Approximately $123 Million
Finster AI secures investment from UBS to advance AI innovation in investment banking
Archer to Shape Physical AI Future of Aerospace and Defense with Acquisition of Boeing’s Wisk Aero, Insitu and SkyGrid Subsidiaries; Boeing to Invest in Archer and Collaborate